Mitoquinone mesylate targets SARS-CoV-2 infection in preclinical models

Anton Petcherski(University of California, Los Angeles), Theodoros Kelesidis(The University of Texas Southwestern Medical Center)
bioRxiv (Cold Spring Harbor Laboratory)
February 25, 2022
Cited by 7


Related Papers